Arena Pharmaceuticals, Inc.

Press Releases



All Releases

View Summary Arena Pharmaceuticals to Present at the Oppenheimer 23rd Annual Healthcare Conference
Dec 6, 2012
PDF 9.9 KB Add to Briefcase
View Summary Arena Pharmaceuticals and Ildong Pharmaceutical Enter Into Co-Development and License Agreement for Temanogrel, a Novel Agent for Thrombotic Diseases
Nov 28, 2012
PDF 12.9 KB Add to Briefcase
View Summary Arena Pharmaceuticals to Webcast Live Presentation at the Piper Jaffray 24th Annual Healthcare Conference
Nov 21, 2012
PDF 10.7 KB Add to Briefcase
View Summary Arena Pharmaceuticals to Present at Two Upcoming Investor Conferences
Nov 8, 2012
PDF 10.8 KB Add to Briefcase
View Summary Arena Pharmaceuticals Provides Corporate Update and Reports Third Quarter 2012 Financial Results
Nov 6, 2012
PDF 24.5 KB Add to Briefcase
View Summary Arena Pharmaceuticals Establishes BELVIQ® (lorcaserin HCl) Marketing and Supply Agreement with Ildong Pharmaceutical for South Korea
Nov 6, 2012
PDF 14.4 KB Add to Briefcase
View Summary Arena Pharmaceuticals to Host Corporate Update and Financial Results Conference Call and Webcast on Tuesday, November 6
Oct 31, 2012
PDF 10.1 KB Add to Briefcase
View Summary Arena Pharmaceuticals Initiates Phase 1 Multiple Dose Clinical Trial of APD811 for Pulmonary Arterial Hypertension
Oct 12, 2012
PDF 10.9 KB Add to Briefcase
View Summary Arena Pharmaceuticals to Present at the UBS Global Life Sciences Conference
Sep 18, 2012
PDF 9.5 KB Add to Briefcase
View Summary Arena Pharmaceuticals to Present at Upcoming Investor Conferences
Aug 30, 2012
PDF 11.3 KB Add to Briefcase
View Summary Arena Pharmaceuticals Announces Second Quarter 2012 Financial Results and Recent Developments
Aug 9, 2012
PDF 25.5 KB Add to Briefcase
View Summary Arena Pharmaceuticals to Host Business and Financial Update Conference Call and Webcast on Thursday, August 9
Aug 2, 2012
PDF 10.2 KB Add to Briefcase
View Summary Eisai and Arena Pharmaceuticals Complete Transfer of BELVIQ® (lorcaserin HCl) New Drug Application
Jul 30, 2012
PDF 12.5 KB Add to Briefcase
View Summary Arena Pharmaceuticals Files Marketing Authorization Application in Switzerland for Lorcaserin as a Treatment for Weight Control
Jul 11, 2012
PDF 11.2 KB Add to Briefcase
View Summary Arena Pharmaceuticals to Present at the Seventh Annual JMP Securities Healthcare Conference
Jul 9, 2012
PDF 9.7 KB Add to Briefcase
View Summary Arena Pharmaceuticals Promotes Craig M. Audet to Executive Officer as Senior Vice President, Operations and Head of Global Regulatory Affairs
Jul 5, 2012
PDF 11.0 KB Add to Briefcase
View Summary Arena Pharmaceuticals and Eisai Announce FDA Approval of BELVIQ® (lorcaserin HCl) for Chronic Weight Management in Adults who are Overweight with a Comorbidity or Obese
Jun 27, 2012
PDF 23.0 KB Add to Briefcase
View Summary Arena Pharmaceuticals Announces Exercise in Full of Over-Allotment Option and Completion of Public Offering of Common Stock
May 21, 2012
PDF 11.5 KB Add to Briefcase
View Summary Arena Pharmaceuticals Prices Public Offering of Common Stock
May 16, 2012
PDF 11.6 KB Add to Briefcase
View Summary Arena Pharmaceuticals Announces Proposed Public Offering of Common Stock
May 15, 2012
PDF 12.4 KB Add to Briefcase
Showing 41-60 of 441 Page: 1 2 3 4 5 6 7 ... 23  Previous 20 | Next 20
Add to Briefcase = add release to Briefcase